Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.44+0.02 (+0.45%)
Close on Nov 17, 2026Market cap $288.75MP/E –Yield –
Treace Medical Concepts cash
Cash and short-term investments held at the end of each period.
Treace Medical Concepts's cash was $45.62M at Jun 30, 2026. For fiscal 2025 it was $48.37M, down 36.1% from the year before. The highest annual figure on record is $123.20M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.37M | -36.1% |
| FY2024 | Dec 31, 2024 | $75.68M | -38.6% |
| FY2023 | Dec 31, 2023 | $123.20M | +51.6% |
| FY2022 | Dec 31, 2022 | $81.25M | -23.2% |
| FY2021 | Dec 31, 2021 | $105.83M | +485.4% |
| FY2020 | Dec 31, 2020 | $18.08M | +48.9% |
| FY2019 | Dec 31, 2019 | $12.14M | +845.4% |
| FY2018 | Dec 31, 2018 | $1.28M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $45.62M | -34.2% |
| Q1 FY2026 | Mar 31, 2026 | $51.85M | -31.9% |
| Q4 FY2025 | Dec 31, 2025 | $48.37M | -36.1% |
| Q3 FY2025 | Sep 30, 2025 | $57.42M | -30.7% |
| Q2 FY2025 | Jun 30, 2025 | $69.29M | -27.1% |
| Q1 FY2025 | Mar 31, 2025 | $76.09M | -30.8% |
| Q4 FY2024 | Dec 31, 2024 | $75.68M | -38.6% |
| Q3 FY2024 | Sep 30, 2024 | $82.80M | -32.2% |
| Q2 FY2024 | Jun 30, 2024 | $95.05M | -31.9% |
| Q1 FY2024 | Mar 31, 2024 | $110.01M | -35.5% |
| Q4 FY2023 | Dec 31, 2023 | $123.20M | +51.6% |
| Q3 FY2023 | Sep 30, 2023 | $122.16M | +38.0% |
| Q2 FY2023 | Jun 30, 2023 | $139.48M | +37.4% |
| Q1 FY2023 | Mar 31, 2023 | $170.66M | +73.3% |
| Q4 FY2022 | Dec 31, 2022 | $81.25M | -23.2% |
| Q3 FY2022 | Sep 30, 2022 | $88.55M | -19.1% |
| Q2 FY2022 | Jun 30, 2022 | $101.53M | -15.1% |
| Q1 FY2022 | Mar 31, 2022 | $98.48M | +507.2% |
| Q4 FY2021 | Dec 31, 2021 | $105.83M | +485.4% |
| Q3 FY2021 | Sep 30, 2021 | $109.46M | +611.0% |
| Q2 FY2021 | Jun 30, 2021 | $119.62M | +1060.8% |
| Q1 FY2021 | Mar 31, 2021 | $16.22M | +53.0% |
| Q4 FY2020 | Dec 31, 2020 | $18.08M | +48.9% |
| Q3 FY2020 | Sep 30, 2020 | $15.40M | +1099.1% |
| Q2 FY2020 | Jun 30, 2020 | $10.31M | – |
| Q1 FY2020 | Mar 31, 2020 | $10.60M | – |
| Q4 FY2019 | Dec 31, 2019 | $12.14M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.28M | – |
See a number that looks wrong?